NICE rejects asthma drug for under-12s

NICE has rejected asthma drug omalizumab (Xolair) for children under the age of 12 in the NHS in England and issued guidance on fracture prevention, bed-wetting treatments and the diabetes drug liraglutide.

Omalizumab is recommended for some over-12s, but NICE said that the evidence for use in younger children suggested the drug offered limited benefits over other treatments. The extra cost of the drug would not therefore represent good value for money, it concluded.

But the guidance states that children currently receiving omalizumab should be able to continue with the treatment until it is considered appropriate to stop.

This week the institute recommended denosumab (Prolia) as a treatment option for some postmenopausal women at increased risk of osteoporotic fractures if other treatments available on the NHS are unsuitable.

NICE has also published the first national guidance on how to treat children and young people who wet the bed. In a change to current clinical practice, the institute has not specified a minimum age limit in its new clinical guideline on the assessment and management of this condition.

The institute said the new recommendations meant healthcare professionals would now be more likely to consider whether younger children may benefit from appropriate advice and treatments currently available on the NHS.

NICE has issued final guidance approving the use of the drug liraglutide for certain diabetes patients. PCTs must now fund the drug for eligible patients recommended for treatment with it by their clinicians. Draft guidance on liraglutide was issued in September. The final guidance setting out which patients are eligible for treatment is available on the NICE website.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK Houses of Parliament

Scrapping partnership model will not solve crisis in general practice, say NHS leaders

Scrapping the partnership model and moving to a salaried service will not solve the...

Dr Jackie Applebee

Doctors tell BMA to pull GP practices out of PCNs by 2023

The BMA has been told to organise the withdrawal of GP practices from PCNs by 2023...

GP consultation

3 in 10 doctors fear being blamed or facing legal action after admitting mistakes

Three in 10 doctors are worried about the repercussions of admitting to clinical...

BMA House entrance

Only 55% of Romney review recommendations on BMA sexism fully implemented

Only just over half of recommendations from the 2019 Romney review into sexism in...

BMA House entrance

GPs face pension tax penalties worth 'half their post-tax income'

Rapid swings in inflation could leave GPs facing pension tax penalties worth 'half...

Banknotes

BMA to demand significant pay rises to combat 15 years of real-term cuts

The BMA is set to demand significant pay rises for all doctors to undo over a decade...